Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06584812
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-08-29
Brief Title:
Study to Assess Pharmacokinetics Pharmacodynamics and Safety of Tiprogrel in Healthy Subjects
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase I Study to Evaluate the Pharmacokinetics Pharmacodynamics and Safety in Healthy Subjects With Multiple Administration of Tiprogrel
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is designed to evaluate the pharmacokinetics pharmacodynamics and safety in healthy subjects with multiple administration of Tiprogrel
Detailed Description:
Tiprogrel is a novel oral P2Y12 receptor antagonistThis study is to evaluate the pharmacokinetics pharmacodynamics and safety in healthy subjects with multiple administration of Tiprogrel and compare pharmacokinetics pharmacodynamic of TiprogrelClopidogrel and Ticagrelor
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None